Pharma-Bio Serv, Inc. (PBSV)
OTCMKTS: PBSV · Delayed Price · USD
0.650
0.00 (0.00%)
Jul 23, 2024, 4:00 PM EDT - Market closed

Pharma-Bio Serv Revenue

Pharma-Bio Serv had revenue of $12.93M in the twelve months ending April 30, 2024. Revenue in the quarter ending April 30, 2024 was $2.38M. In the fiscal year ending October 31, 2023, Pharma-Bio Serv had annual revenue of $16.98M.

Revenue (ttm)
$12.93M
Revenue Growth
-28.99%
P/S Ratio
1.15
Revenue / Employee
$129,332
Employees
100
Market Cap
14.92M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Oct 31, 202316.98M-2.42M-12.48%
Oct 31, 202219.40M-716.45K-3.56%
Oct 31, 202120.12M-1.45M-6.72%
Oct 31, 202021.56M2.06M10.55%
Oct 31, 201919.51M1.71M9.61%
Oct 31, 201817.80M2.22M14.24%
Oct 31, 201715.58M-3.96M-20.26%
Oct 31, 201619.54M-3.85M-16.46%
Oct 31, 201523.38M-4.17M-15.13%
Oct 31, 201427.56M-5.51M-16.66%
Oct 31, 201333.06M3.83M13.12%
Oct 31, 201229.23M9.29M46.63%
Oct 31, 201119.93M8.59M75.68%
Oct 31, 201011.35M-132.63K-1.16%
Oct 31, 200911.48M-3.72M-24.46%
Oct 31, 200815.20M-1.01M-6.22%
Oct 31, 200716.20M1.98M13.88%
Oct 31, 200614.23M14.22M142,198.31%
Jun 30, 200510.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 379.49B
Johnson & Johnson 81.80B
Merck & Co. 61.40B
AbbVie 54.40B
Novartis AG 48.86B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Revenue Rankings